Diabetes treatment is constantly progressing, with new therapeutic options emerging to improve patient outcomes. Recent studies have focused on GLP-1 and GIP receptor agonists, a class of drugs that mimic the actions https://jasperdpoi978782.ka-blogs.com/92250192/novel-glp-1-and-gip-receptor-agonists-a-new-era-in-diabetes-treatment